An observational study in Perimyocarditis and Covid19, sponsored by Hillel Yaffe Medical Center. Status unknown at 1 site in Israel. Open to participants aged 16 Years to 60 Years. Per ClinicalTrials.gov, last updated 2021-04-29.
Sponsored by Hillel Yaffe Medical Center · Observational
The aim of this study is to determine whether there is a higher prevalence of perimyocarditis after undergoing vaccination for Covid-19.
7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's planned enrollment of 500 is above the median of 260 across 3,135 observational studies indexed under COVID-19.
Browse COVID-19 studies →Hillel Yaffe Medical Center is the lead sponsor of 301 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient Registries from local Health Maintenance Organizations
Exclusion Criteria:
Patients who are planning to receive Pfizer-BioNTech BNT162b2 vaccines against Covid19
Diagnostic Test: Laboratory Blood Tests · Diagnostic Test: ECG · Diagnostic Test: PCR · Diagnostic Test: Antibody test · Diagnostic Test: Echocardiography · Diagnostic Test: MRI
Blood tests to determine liver and kidney functioning, total blood count, and troponin levels
ECG to determine heart rate and functioning
PCR test to determine whether patient has Covid19
Antibody test to determine level of antibodies to Covid19
If Troponin level elevated echocardiography to determine heart function
If Troponin level elevated MRI to determine heart function
Elevated Troponin
Laboratory blood tests will be taken before and after Covid19 vaccination and compared. Troponin levels above normal range of 0.4 ng/ml will indicate possibility of perimyocarditis and patient will referred for additional testing.
Time frame: 4 weeks
This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hillel Yaffe Medical Center